Fierce Pharma Layoff Tracker 2024. Fierce biotech layoff tracker '24: The move comes as pfizer cuts costs around the globe to save $4 billion annually by the end of 2024 in response to declining covid product sales.
Every year, fierce puts together a special report ranking the top 10 companies by generic drug sales. The top line sarepta therapeutics abbott fda approval.
The Workforce Reduction Was Slated To Take Place Over Two Weeks From Jan.
We discuss those rankings and also the interesting.
Layoffs Have Hit Biopharma Hard Over The Last Year And A Half.
Perrigo’s restructuring plan came as the company reported $4.7 billion in sales for its 2023 fiscal year, up 4.6% from 2022.
Videos Cannot Play Due To A Network Issue.
Images References :
Perrigo’s Restructuring Plan Came As The Company Reported $4.7 Billion In Sales For Its 2023 Fiscal Year, Up 4.6% From 2022.
As always, if you know of a layoff occurring at a biotech, please reach out to the fierce biotech.
Biotech Layoffs Continue To Pummel The Industry In Early 2024.
The move comes as pfizer cuts costs around the globe to save $4 billion annually by the end of 2024 in response to declining covid product sales.
Layoffs Have Hit Biopharma Hard Over The Last Year And A Half.